Development and Validation Clinician and Patient Reported Photonumeric Scales to Assess Buttocks Cellulite Severity

被引:15
|
作者
Cohen, Joel L. [1 ,2 ]
Sadick, Neil S. [3 ]
Kirby, M. Todd [4 ]
McLane, Michael P. [4 ]
Lenderking, William R. [5 ]
Bender, Randall H. [5 ,6 ]
Chen, Jun [5 ]
Hurley, David [4 ]
Knoble, Naomi B. [5 ]
Liu, Genzhou [4 ]
Xiang, Qinfang [4 ]
Davidson, Jeffrey A. [4 ]
Goldman, Mitchel P. [7 ,8 ]
机构
[1] AboutSkin Dermatol & DermSurg PC, 5340 South Quebec St,Suite 300, Greenwood Village, CO 80111 USA
[2] Univ Calif Irvine, Dermatol, Irvine, CA USA
[3] Cornell Univ, Dept Dermatol, Weill Cornell Med Coll, New York, NY 10021 USA
[4] Endo Pharmaceut Inc, Malvern, PA USA
[5] Evidera, Bethesda, MD USA
[6] Univ N Carolina, Dept Anesthesiol, Chapel Hill, NC 27515 USA
[7] Cosmet Laser Dermatol, San Diego, CA USA
[8] Univ Calif San Diego, Dermatol, San Diego, CA 92103 USA
关键词
D O I
10.1097/DSS.0000000000002756
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
BACKGROUND The Clinician Reported Photonumeric Cellulite Severity Scale (CR-PCSS) and Patient Reported PCSS (PR-PCSS) are newly developed tools for assessing cellulite severity. OBJECTIVE To report on the reliability, validity, and ability to detect a change in cellulite severity on the buttocks of adult women with the CR-PCSS and PR-PCSS. MATERIALS AND METHODS Content validity of both scales was established through concept elicitation and cognitive interviews. Test-retest reliability was evaluated, and intra-rater (both scales) and inter-rater (CR-PCSS only) reliability were estimated using intraclass correlation coefficients (ICCs) for agreement and consistency. Ability to detect a change was determined using the Subject-Global Aesthetic Improvement Scale (GAIS) or Investigator-GAIS as anchors. RESULTS For the CR-PCSS (n = 6) at baseline and Day 2, the mean interrater ICCs were $0.70 and mean intrarater ICCs (95% confidence interval [CI]) were $0.81 (0.72-0.90) for both buttocks. For the PR-PCSS (n = 99) at baseline and Day 14, the mean test-retest reliability ICCs (95% CI) were $0.86 (0.79-0.91) for both buttocks. A clinically meaningful change was 1.0 point on the PR-PCSS and 1.0 on the CR-PCSS. CONCLUSION The CR-PCSS and PR-PCSS reliably assess cellulite severity of the buttocks and can detect a clinically meaningful change after treatment for cellulite.
引用
收藏
页码:1628 / 1635
页数:8
相关论文
共 50 条
  • [11] Validation of the Psoriasis Symptom Inventory (PSI), a patient-reported outcome measure to assess psoriasis symptom severity
    Bushnell, Donald M.
    Martin, Mona L.
    McCarrier, Kelly
    Gordon, Kenneth
    Chiou, Chiun-Fang
    Huang, Xingyue
    Ortmeier, Brian
    Kricorian, Gregory
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2013, 24 (05) : 356 - 360
  • [12] Clinician (ClinRO) and Caregiver (ObsRO) reported severity assessments for respiratory syncytial virus (RSV) in infants and young children: Development and qualitative content validation of Pediatric RSV Severity and Outcome Rating Scales (PRESORS)
    Scott, Jane
    Tatlock, Sophi
    Kilgariff, Sarah
    Arbuckle, Rob
    Abetz-Webb, Linda
    Rusch, Sarah
    Steven, Marita
    QUALITY OF LIFE RESEARCH, 2018, 27 : S132 - S133
  • [13] Development and Validation of a Patient-Reported Outcome Measure to Assess Disease Control in Chronic Prurigo
    Metz, Martin
    Zeidler, Claudia
    Hawro, Tomasz
    Pereira, Manuel
    Maurer, Marcus
    Bonnekoh, Hanna
    Krause, Karoline
    Pritchard, Thomas
    Kwatra, Shawn G.
    Staender, Sonja
    Weller, Karsten
    JAMA DERMATOLOGY, 2024, 160 (02) : 187 - 193
  • [14] Development and validation of the scale to assess severity of substance use
    Kukreti, Prerna
    INDIAN JOURNAL OF PSYCHIATRY, 2024, 66 : S149 - S149
  • [15] Response Inconsistency of Patient-Reported Symptoms as a Predictor of Discrepancy Between Patient and Clinician-Reported Depression Severity
    Conijn, Judith M.
    Emons, Wilco H. M.
    Page, Bethan F.
    Sijtsma, Klaas
    Van der Does, Willem
    Carlier, Ingrid V. E.
    Giltay, Erik J.
    ASSESSMENT, 2018, 25 (07) : 917 - 928
  • [16] Psychometric validation of two patient-reported outcome measures to assess symptom severity and changes in symptoms in hereditary angioedema
    Margaret K. Vernon
    Anne M. Rentz
    Kathleen W. Wyrwich
    Martha V. White
    Aurelie Grienenberger
    Quality of Life Research, 2009, 18 : 929 - 939
  • [17] Psychometric validation of two patient-reported outcome measures to assess symptom severity and changes in symptoms in hereditary angioedema
    Vernon, Margaret K.
    Rentz, Anne M.
    Wyrwich, Kathleen W.
    White, Martha V.
    Grienenberger, Aurelie
    QUALITY OF LIFE RESEARCH, 2009, 18 (07) : 929 - 939
  • [18] Development of a clinician questionnaire and patient interview to assess reasons for antipsychotic discontinuation
    Matza, Louis S.
    Phillips, Glenn A.
    Revicki, Dennis A.
    Ascher-Svanum, Haya
    Kaiser, Dawn
    Stauffer, Virginia
    Shorr, Jodi M.
    Kinon, Bruce J.
    PSYCHIATRY RESEARCH, 2011, 189 (03) : 463 - 468
  • [19] Development of a patient-reported outcome (PRO) measure to assess symptom severity and change in hereditary angioedema (HAE)
    White, M.
    Vernon, M. K.
    Rentz, A.
    Horn, P.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2008, 100 (01) : A80 - A80
  • [20] Development and initial validation of the Asthma Severity Scoring System (ASSESS)
    Fitzpatrick, Anne M.
    Szefler, Stanley J.
    Mauger, David T.
    Phillips, Brenda R.
    Denlinger, Loren C.
    Moore, Wendy C.
    Sorkness, Ronald L.
    Wenzel, Sally E.
    Gergen, Peter J.
    Bleecker, Eugene R.
    Castro, Mario
    Erzurum, Serpil C.
    Fahy, John, V
    Gaston, Benjamin M.
    Israel, Elliot
    Levy, Bruce D.
    Meyers, Deborah A.
    Teague, W. Gerald
    Bacharier, Leonard B.
    Ly, Ngoc P.
    Phipatanakul, Wanda
    Ross, Kristie R.
    Zein, Joe
    Jarjour, Nizar N.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 145 (01) : 127 - 139